TrialBritish journal of clinical pharmacology2016

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

Aili L Lazaar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.